Precigen Inc (PGEN)
Healthcare
Biotechnology
6.60 $
+5.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Precigen Inc (PGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -88 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | 36 | -56 | -104 | -124 | -77 | -77 | -56 | -65 | -67 | -68 | -88 | |
| 10 | 18 | 25 | 31 | 33 | 18 | 18 | 14 | 11 | 6.7 | 4.5 | 3.2 | |
| 22 | 100 | 53 | 53 | 47 | 18 | 18 | 14 | 10 | 9.9 | 9.5 | 11 | |
| 39 | 52 | 64 | 74 | 111 | 150 | 48 | 12 | 11 | – | – | – | |
| 12 | 59 | -18 | -75 | -20 | -21 | -21 | -0.8 | -36 | 17 | 4.5 | 6.6 | |
| 6.4 | 13 | 32 | 47 | 42 | 7.5 | 7.5 | 7.2 | 4.9 | 1.5 | 8.6 | 2.0 | |
| -26 | -261 | -28 | 104 | -151 | 28 | 28 | -75 | 226 | -3.1 | -21 | -1.5 | |
| 7.0 | – | 42 | 7.7 | – | – | – | – | – | – | – | – | |
| -0.5 | 343 | -0.5 | -0.5 | 2.3 | 0.3 | 35 | 0.6 | 0.0 | 0.0 | 0.0 | -2.2 | |
| -2.2 | -3.2 | -0.4 | -0.8 | 219 | 1.2 | -2.4 | -0.5 | -155 | -43 | 0.0 | 93 | |
| 24 | 333 | 12 | 4.3 | 310 | 33 | 33 | 121 | -155 | 30 | 111 | 90 | |
| -22 | 108 | -73 | 5.5 | 35 | -16 | -16 | -8.9 | 5.3 | -41 | 22 | 0.7 | |
| -26 | 23 | -88 | -151 | -166 | -85 | -85 | -63 | -70 | -68 | -77 | -90 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.